Exploiting pre-existing viral immunity for B cell vaccination against endogenous antigens
<p>Cancer vaccines are a novel method of treating cancer by harnessing the patient’s own immune system to recognise and attack malignant cells. Viral vectors can be used to encode tumour antigens to be presented to the immune system. However this field is hindered by immunity to the viral vect...
主要作者: | Wong, S |
---|---|
其他作者: | Seymour, L |
格式: | Thesis |
語言: | English |
出版: |
2013
|
主題: |
相似書籍
-
CEA-targeted monoclonal antibody therapy in colorectal cancer
由: Conaghan, P, et al.
出版: (2009) -
Evaluation of the immunogenicity of a promising vaccine regimen to identify immune correlates of protection
由: Pinpathomrat, N
出版: (2018) -
Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
由: Antrobus, R
出版: (2014) -
Biodegradable pulsatile release technologies for viral vector based vaccinations
由: Krastev, C
出版: (2018) -
Novel adenoviral vectored vaccines and the implications of viral diversity in therapeutic strategies against Hepatitis C Virus infection
由: Kelly, C
出版: (2013)